- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical implications of germline mutations in breast cancer genes: RECQL ; day:4 ; month:1 ; year:2019 ; pages:1-8
Breast cancer research and treatment ; (4.1.2019), 1-8
- Creator
-
Bowden, A. Ramsay
Tischkowitz, Marc
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-018-05096-6
- URN
-
urn:nbn:de:101:1-2019020920250019936053
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bowden, A. Ramsay
- Tischkowitz, Marc
- SpringerLink (Online service)
Other Objects (12)
Clinical implications of germline mutations in breast cancer: TP53
Germline breast cancer susceptibility gene mutations and breast cancer outcomes
Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations
Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patients
Use of SDHB immunohistochemistry to identify germline mutations of SDH genes
Germline breast cancer susceptibility genes, tumor characteristics, and survival
BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients
No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2in familial breast cancer with linkage to 19p
Depletion of loss-of-function germline mutations in centenarians reveals longevity genes
Breast cancer and ATM mutations: treatment implications
Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
Clinical implications of germline mutations in breast cancer: TP53
Germline breast cancer susceptibility gene mutations and breast cancer outcomes
Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations
Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patients
Use of SDHB immunohistochemistry to identify germline mutations of SDH genes
Germline breast cancer susceptibility genes, tumor characteristics, and survival
BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients
No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2in familial breast cancer with linkage to 19p
Depletion of loss-of-function germline mutations in centenarians reveals longevity genes
Breast cancer and ATM mutations: treatment implications
Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
Clinical implications of germline mutations in breast cancer: TP53
Germline breast cancer susceptibility gene mutations and breast cancer outcomes
Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations
Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patients
Use of SDHB immunohistochemistry to identify germline mutations of SDH genes
Germline breast cancer susceptibility genes, tumor characteristics, and survival
BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients
No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2in familial breast cancer with linkage to 19p
Depletion of loss-of-function germline mutations in centenarians reveals longevity genes
Breast cancer and ATM mutations: treatment implications